Travere Therapeutics, Inc. (TVTX)
USD 14.51
(-3.2%)
USD 14.51
(-3.2%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 472 Million USD | 2.11% |
| 2022 | 455.98 Million USD | 26.59% |
| 2021 | 360.21 Million USD | 34.62% |
| 2020 | 267.57 Million USD | -0.87% |
| 2019 | 269.91 Million USD | 18.69% |
| 2018 | 227.41 Million USD | 24.86% |
| 2017 | 182.12 Million USD | 7.85% |
| 2016 | 168.86 Million USD | 29.93% |
| 2015 | 129.96 Million USD | 20.97% |
| 2014 | 107.43 Million USD | 348.19% |
| 2013 | 23.97 Million USD | -20.77% |
| 2012 | 30.25 Million USD | 235822.16% |
| 2011 | 12.82 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 13.43 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 178.84 Million USD | 60.43% |
| 2024 Q3 | 119.04 Million USD | 7.96% |
| 2024 Q2 | 108.76 Million USD | -39.19% |
| 2023 Q4 | 111.48 Million USD | -14.03% |
| 2023 Q2 | 143.44 Million USD | 8.54% |
| 2023 Q3 | 129.68 Million USD | -9.6% |
| 2023 FY | 465.6 Million USD | 2.11% |
| 2023 Q1 | 132.15 Million USD | 7.31% |
| 2022 Q3 | 116.77 Million USD | 3.65% |
| 2022 Q4 | 123.15 Million USD | 5.46% |
| 2022 FY | 455.98 Million USD | 26.59% |
| 2022 Q2 | 112.66 Million USD | 8.96% |
| 2022 Q1 | 103.39 Million USD | -0.81% |
| 2021 FY | 360.21 Million USD | 34.62% |
| 2021 Q4 | 104.24 Million USD | 23.41% |
| 2021 Q1 | 84.72 Million USD | 20.47% |
| 2021 Q2 | 86.77 Million USD | 2.42% |
| 2021 Q3 | 84.47 Million USD | -2.65% |
| 2020 Q4 | 70.32 Million USD | 9.38% |
| 2020 Q3 | 64.3 Million USD | -2.22% |
| 2020 Q1 | 61.46 Million USD | -3.81% |
| 2020 Q2 | 65.76 Million USD | 6.99% |
| 2020 FY | 267.57 Million USD | -0.87% |
| 2019 Q3 | 62.29 Million USD | -18.99% |
| 2019 FY | 269.91 Million USD | 18.69% |
| 2019 Q1 | 66.11 Million USD | 14.08% |
| 2019 Q2 | 76.9 Million USD | 16.32% |
| 2019 Q4 | 63.89 Million USD | 2.57% |
| 2018 Q1 | 51.1 Million USD | 9.08% |
| 2018 FY | 227.41 Million USD | 24.86% |
| 2018 Q4 | 57.95 Million USD | -1.03% |
| 2018 Q3 | 58.55 Million USD | -1.69% |
| 2018 Q2 | 59.56 Million USD | 16.55% |
| 2017 Q3 | 44.46 Million USD | -7.98% |
| 2017 Q1 | 43.97 Million USD | -5.84% |
| 2017 FY | 182.12 Million USD | 7.85% |
| 2017 Q4 | 46.85 Million USD | 5.37% |
| 2017 Q2 | 48.31 Million USD | 9.87% |
| 2016 Q1 | 33.79 Million USD | -11.38% |
| 2016 Q3 | 47.48 Million USD | 16.16% |
| 2016 FY | 168.86 Million USD | 29.93% |
| 2016 Q4 | 46.7 Million USD | -1.65% |
| 2016 Q2 | 40.88 Million USD | 20.96% |
| 2015 FY | 129.96 Million USD | 20.97% |
| 2015 Q4 | 38.13 Million USD | 4.86% |
| 2015 Q1 | 25.2 Million USD | -22.83% |
| 2015 Q3 | 36.37 Million USD | 20.22% |
| 2015 Q2 | 30.25 Million USD | 20.05% |
| 2014 Q4 | 32.65 Million USD | 3.36% |
| 2014 FY | 107.43 Million USD | 348.19% |
| 2014 Q1 | 16.97 Million USD | 48.06% |
| 2014 Q2 | 25.03 Million USD | 47.47% |
| 2014 Q3 | 31.59 Million USD | 26.19% |
| 2013 Q4 | 11.46 Million USD | 122.47% |
| 2013 FY | 23.97 Million USD | -20.77% |
| 2013 Q1 | 2.25 Million USD | 71095.32% |
| 2013 Q2 | 5.09 Million USD | 126.61% |
| 2013 Q3 | 5.15 Million USD | 1.07% |
| 2012 Q2 | 3009.00 USD | -19.93% |
| 2012 FY | 30.25 Million USD | 235822.16% |
| 2012 Q3 | 3000.00 USD | -0.3% |
| 2012 Q4 | 3161.00 USD | 5.37% |
| 2012 Q1 | 3758.00 USD | 24.52% |
| 2011 Q1 | 3580.00 USD | 15.82% |
| 2011 Q2 | 3024.00 USD | -15.53% |
| 2011 Q3 | 3025.00 USD | 0.03% |
| 2011 FY | 12.82 Thousand USD | 0.0% |
| 2011 Q4 | 3018.00 USD | -0.23% |
| 2010 Q2 | 3018.00 USD | -70.13% |
| 2010 Q4 | 3091.00 USD | 3.03% |
| 2010 Q3 | 3000.00 USD | -0.6% |
| 2010 Q1 | 10.1 Thousand USD | 234.82% |
| 2010 FY | - USD | 0.0% |
| 2009 Q2 | 4019.00 USD | 0.0% |
| 2009 Q4 | 3018.00 USD | -1.63% |
| 2009 Q3 | 3068.00 USD | -23.66% |
| 2009 FY | - USD | -100.0% |
| 2008 Q2 | 3376.00 USD | 0.0% |
| 2008 Q3 | 3050.00 USD | -9.66% |
| 2008 FY | 13.43 Thousand USD | 0.0% |
| 2008 Q4 | 4251.00 USD | 39.38% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -71.492% |
| Alkermes plc | 996.24 Million USD | 52.622% |
| Agenus Inc. | 78.18 Million USD | -503.714% |
| Aptorum Group Limited | 10.56 Thousand USD | -4467077.74% |
| Ardelyx, Inc. | 169.93 Million USD | -177.751% |
| Dyadic International, Inc. | 9.15 Million USD | -5056.972% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -2021.071% |
| Lantern Pharma Inc. | 17.87 Million USD | -2540.191% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -6911.377% |
| Novavax, Inc. | 779.12 Million USD | 39.419% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -482.273% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -474.24% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -2330.68% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -1494.278% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -788.451% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -24.049% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -1841.867% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -1146.407% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -1433.918% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -457.158% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -2603.798% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -180.226% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -1342.769% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -195.394% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 73.779% |
| AlloVir, Inc. | 180.93 Million USD | -160.871% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -5.892% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -1490.196% |
| Bicycle Therapeutics plc | 216.92 Million USD | -117.591% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -174.576% |
| ChromaDex Corporation | 56.37 Million USD | -737.195% |
| Chimerix, Inc. | 93.38 Million USD | -405.415% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -3293.344% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -213.548% |
| CRISPR Therapeutics AG | 463.49 Million USD | -1.836% |
| Precision BioSciences, Inc. | 92.46 Million USD | -410.477% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -85.795% |
| Fortress Biotech, Inc. | 200.19 Million USD | -135.771% |
| Fortress Biotech, Inc. | 200.19 Million USD | -135.771% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -1341.404% |
| ImmuCell Corporation | 9.61 Million USD | -4807.812% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -199.088% |
| Immix Biopharma, Inc. | 16.14 Million USD | -2824.222% |
| Incyte Corporation | 1.19 Billion USD | 60.352% |
| Innoviva, Inc. | 132.15 Million USD | -257.161% |
| IO Biotech, Inc. | 91.44 Million USD | -416.171% |
| Jaguar Health, Inc. | 42.01 Million USD | -1023.413% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -178.834% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -459.755% |
| ContextLogic Inc. | 387 Million USD | -21.964% |
| MiMedx Group, Inc. | 229.72 Million USD | -105.462% |
| MEI Pharma, Inc. | 34.78 Million USD | -1256.912% |
| NextCure, Inc. | 67.63 Million USD | -597.846% |
| Onconetix, Inc. | 34.9 Million USD | -1252.153% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -3603.138% |
| Opthea Limited | 191.96 Million USD | -145.876% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -17053.822% |
| Vaxcyte, Inc. | 468.04 Million USD | -0.846% |
| PDS Biotechnology Corporation | 43.04 Million USD | -996.526% |
| Precigen, Inc. | 84.18 Million USD | -460.699% |
| Pharming Group N.V. | 225.49 Million USD | -109.322% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -181.243% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -550.445% |
| PureTech Health plc | 144.59 Million USD | -226.426% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -262.345% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -92.53% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -1841.867% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -106.403% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -1429.544% |
| Acelyrin, Inc. | 422.06 Million USD | -11.832% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -3660532.852% |
| Summit Therapeutics Inc. | 87.68 Million USD | -438.287% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -1173.478% |
| Senti Biosciences, Inc. | 94.7 Million USD | -398.392% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -282.024% |
| Elevation Oncology, Inc. | 45.44 Million USD | -938.623% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -1501.69% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -11873.522% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -257.104% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -1284.779% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -5485.162% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -160.342% |
| Seer, Inc. | 110.49 Million USD | -327.19% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -568.615% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -404.934% |
| ESSA Pharma Inc. | 32.13 Million USD | -1368.851% |
| GlycoMimetics, Inc. | 39.28 Million USD | -1101.473% |
| GT Biopharma, Inc. | 13.57 Million USD | -3376.738% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -114.712% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -134.693% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -81.942% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -731.59% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -772.785% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -4649.636% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -16.959% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -2393.539% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -831.099% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -81.778% |
| Aptose Biosciences Inc. | 52.35 Million USD | -801.524% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -3175.432% |
| Soligenix, Inc. | 7.79 Million USD | -5954.994% |
| Century Therapeutics, Inc. | 56.07 Million USD | -741.793% |
| Kura Oncology, Inc. | 165.8 Million USD | -184.675% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -312.204% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -5573.783% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -18919.769% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -338.264% |
| Autolus Therapeutics plc | 196.72 Million USD | -139.929% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -457.546% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -305.315% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -2335.134% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -46.695% |
| GRI Bio, Inc. | 11.33 Million USD | -4065.949% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -6589.654% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -259.777% |
| IGM Biosciences, Inc. | 265.59 Million USD | -77.718% |
| INmune Bio, Inc. | 29.89 Million USD | -1478.813% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -173.539% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1070.805% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -2853.823% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -2898.446% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -660.092% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -338.982% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -71.206% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -56.577% |
| Verastem, Inc. | 92.08 Million USD | -412.578% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -2531.15% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -154.14% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -288.777% |
| Histogen Inc. | 14.27 Million USD | -3207.189% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -2841.163% |
| Surrozen, Inc. | 18.55 Million USD | -2444.485% |
| Organovo Holdings, Inc. | 14.91 Million USD | -3064.613% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -9172.694% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -690.979% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -1740.379% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -904.131% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -6083.83% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -164.967% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -874.245% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -92.651% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -2971.615% |
| Apollomics, Inc. | 54.14 Million USD | -771.818% |
| Amarin Corporation plc | 272.35 Million USD | -73.303% |
| Mesoblast Limited | 5.9 Million USD | -7897.323% |
| Turnstone Biologics Corp. | 78.33 Million USD | -502.52% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -93.347% |
| Synaptogenix, Inc. | 8.31 Million USD | -5577.295% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -3135.993% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -86.521% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -1316.144% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -5244.688% |
| Exelixis, Inc. | 1.58 Billion USD | 70.254% |
| Better Therapeutics, Inc. | 38.26 Million USD | -1133.605% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -103.405% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | 44.808% |
| NLS Pharmaceutics AG | 11.8 Million USD | -3897.624% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -5769.28% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -1473.707% |
| Gritstone bio, Inc. | 148.37 Million USD | -218.116% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -585.442% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -2785.059% |
| Avid Bioservices, Inc. | 25.99 Million USD | -1715.672% |
| Insmed Incorporated | 949.26 Million USD | 50.277% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -2908.339% |
| MediWound Ltd. | 18.86 Million USD | -2401.601% |
| OmniAb, Inc. | 83.89 Million USD | -462.61% |
| Alector, Inc. | 248.8 Million USD | -89.71% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -101.445% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -803.336% |
| Zai Lab Limited | 547.47 Million USD | 13.786% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -18.399% |
| Aura Biosciences, Inc. | 84.99 Million USD | -455.355% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -90.987% |
| Immunic, Inc. | 99.22 Million USD | -375.698% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -196.834% |
| Veracyte, Inc. | 357.93 Million USD | -31.869% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 94.765% |
| FibroGen, Inc. | 398.11 Million USD | -18.56% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -3221.619% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -6752.579% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -6523.909% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 85.502% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -1724.303% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -49.111% |
| TG Therapeutics, Inc. | 198.47 Million USD | -137.814% |
| Galecto, Inc. | 35.62 Million USD | -1224.844% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -1060.024% |
| Fortrea Holdings Inc. | 457.3 Million USD | -3.215% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -769.601% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -1534.469% |
| XBiotech Inc. | 37.51 Million USD | -1158.336% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -585.442% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -2185.835% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -232.253% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -376.409% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -326.318% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 50.743% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -1536.339% |
| Vaxxinity, Inc. | 56.05 Million USD | -742.094% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -9.605% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -2015.812% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -325.737% |
| NexImmune, Inc. | 28.16 Million USD | -1575.697% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -8433.835% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -2537.986% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 83.234% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -1753.969% |
| Scopus BioPharma Inc. | 11.71 Million USD | -3929.082% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -271.474% |
| Ainos, Inc. | 12.95 Million USD | -3544.054% |
| Pluri Inc. | 22.48 Million USD | -1999.653% |
| Prothena Corporation plc | 282.4 Million USD | -67.136% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -135.975% |
| Celularity Inc. | 215.05 Million USD | -119.477% |
| Rallybio Corporation | 78.93 Million USD | -497.986% |
| Cue Biopharma, Inc. | 19.54 Million USD | -2315.321% |
| MeiraGTx Holdings plc | 151.07 Million USD | -212.423% |
| Omeros Corporation | 94.75 Million USD | -398.15% |
| Humacyte, Inc. | 23.49 Million USD | -1908.776% |
| Immunocore Holdings plc | 308.04 Million USD | -53.228% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -13823.363% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -443.374% |
| Blueprint Medicines Corporation | 722.86 Million USD | 34.704% |
| CalciMedica, Inc. | 21.81 Million USD | -2063.46% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -532.202% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -194.009% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -175.549% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -60.033% |
| Pulmatrix, Inc. | 22.03 Million USD | -2041.764% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -1265.154% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -431.139% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | 14.425% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -550.58% |
| Cytokinetics, Incorporated | 173.61 Million USD | -171.872% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -1271.341% |
| Nutriband Inc. | 5.73 Million USD | -8131.591% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -982.251% |
| Vor Biopharma Inc. | 126.03 Million USD | -274.498% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 60.309% |
| Evogene Ltd. | 27.79 Million USD | -1598.46% |
| ProKidney Corp. | 151.52 Million USD | -211.507% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -536.336% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -6036.078% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | 23.155% |
| CorMedix Inc. | 48.95 Million USD | -864.1% |
| BioLineRx Ltd. | 50.8 Million USD | -829.101% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -213.206% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -1139.762% |
| Atai Life Sciences N.V. | 125.78 Million USD | -275.245% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -478.155% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -479.791% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -86.893% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -1341.668% |
| MediciNova, Inc. | 10.9 Million USD | -4230.188% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -266.404% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -6401.831% |
| GeoVax Labs, Inc. | 6.02 Million USD | -7737.736% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | 0.915% |
| Biomea Fusion, Inc. | 126.13 Million USD | -274.204% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 64.02% |
| Mereo BioPharma Group plc | 35.84 Million USD | -1216.896% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -147.006% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -105.259% |
| Absci Corporation | 73.66 Million USD | -540.732% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -1611.268% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -253.321% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -94.912% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -80.12% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -126.931% |
| Allakos Inc. | 196.05 Million USD | -140.749% |
| Imunon, Inc. | 20.31 Million USD | -2223.94% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -315.974% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -28.048% |
| BioAtla, Inc. | 129.68 Million USD | -263.955% |
| NLS Pharmaceutics AG | 11.8 Million USD | -3897.624% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -2879.246% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -455.833% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -1030.327% |
| XOMA Corporation | 46.46 Million USD | -915.866% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -324.573% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -231.315% |
| aTyr Pharma, Inc. | 12.97 Million USD | -3536.659% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -355.354% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -173.039% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -85.27% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -1161.768% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -5638.756% |
| Akari Therapeutics, Plc | 16.8 Million USD | -2708.533% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -20656.738% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -57.692% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -6914.726% |
| UroGen Pharma Ltd. | 138.88 Million USD | -239.844% |
| Sutro Biopharma, Inc. | 243 Million USD | -94.232% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -6388.337% |
| Orgenesis Inc. | 45.75 Million USD | -931.541% |
| Entera Bio Ltd. | 8.86 Million USD | -5227.336% |
| GH Research PLC | 41.22 Million USD | -1045.025% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -1736.012% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -468.314% |
| Xencor, Inc. | 306.97 Million USD | -53.758% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -9467.079% |
| Replimune Group, Inc. | 234.77 Million USD | -101.046% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -2203.585% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -146.096% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -6914.726% |
| Portage Biotech Inc. | 18.19 Million USD | -2493.56% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -6401.831% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -349.693% |
| OncoCyte Corporation | 25.63 Million USD | -1741.097% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -7643.314% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -4019.748% |
| Purple Biotech Ltd. | -22.46 Million USD | 2200.868% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -2764.09% |
| scPharmaceuticals Inc. | 65.17 Million USD | -624.174% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -5484.014% |
| HilleVax, Inc. | 133.34 Million USD | -253.971% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -4489.227% |
| Tharimmune, Inc. | 9.45 Million USD | -4891.973% |
| Genprex, Inc. | 31.06 Million USD | -1419.618% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -151.699% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -1404.293% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -61599.608% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -8565.486% |
| OKYO Pharma Limited | 8243.57 USD | -5725598.939% |
| Savara Inc. | 15.74 Million USD | -2897.79% |
| Curis, Inc. | 58.35 Million USD | -708.846% |
| Daré Bioscience, Inc. | 33.6 Million USD | -1304.375% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -9168.593% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -6226.257% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -1646.732% |
| BeiGene, Ltd. | 3.28 Billion USD | 85.639% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -2267.194% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | 5.366% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -207.189% |
| Erasca, Inc. | 141.52 Million USD | -233.511% |
| bluebird bio, Inc. | 240.23 Million USD | -96.478% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -10326.435% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 72.971% |
| DBV Technologies S.A. | 92.16 Million USD | -412.155% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -10326.435% |
| Moderna, Inc. | 6.39 Billion USD | 92.618% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -1007.752% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -3185.549% |
| Molecular Templates, Inc. | 63.09 Million USD | -648.129% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -607.639% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -229.355% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -660.288% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -987.211% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -126.782% |
| MacroGenics, Inc. | 217.21 Million USD | -117.297% |
| RenovoRx, Inc. | 11.39 Million USD | -4041.822% |
| Adicet Bio, Inc. | 152.03 Million USD | -210.45% |
| Prime Medicine, Inc. | 186.63 Million USD | -152.896% |
| Aditxt, Inc. | 25.95 Million USD | -1718.837% |
| Adagene Inc. | 41.83 Million USD | -1028.345% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -6356.849% |
| Quantum-Si incorporated | 111.65 Million USD | -322.717% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -174.659% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -3137.821% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -1217.632% |
| SciSparc Ltd. | 9.01 Million USD | -5138.065% |
| Vericel Corporation | 142.04 Million USD | -232.302% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -5352.47% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -1944.308% |
| Generation Bio Co. | 144.46 Million USD | -226.72% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -468.472% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -445.92% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -59.611% |
| Invivyd, Inc. | 205.75 Million USD | -129.4% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -554.114% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -4932.807% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -527.212% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -4488.335% |
| 2seventy bio, Inc. | 289.88 Million USD | -62.823% |
| ADMA Biologics, Inc. | 66.58 Million USD | -608.861% |
| Clene Inc. | 41.07 Million USD | -1049.178% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -3585.245% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -761.38% |
| GeoVax Labs, Inc. | 6.02 Million USD | -7737.736% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -34.073% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -1184.988% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -1299.437% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -355.152% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -1348.348% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -177.195% |
| Vir Biotechnology, Inc. | 767.72 Million USD | 38.519% |
| Evaxion Biotech A/S | 22.27 Million USD | -2019.452% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -248.228% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -100.953% |
| Trevena, Inc. | 38.41 Million USD | -1128.756% |
| Surrozen, Inc. | 18.55 Million USD | -2444.485% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -490.408% |
| Cingulate Inc. | 22.75 Million USD | -1973.896% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 6400.08% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -956.713% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -5632.395% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -360.229% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | 37.407% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -660.386% |
| Clearmind Medicine Inc. | 8.74 Million USD | -5299.647% |
| Kronos Bio, Inc. | 128.11 Million USD | -268.412% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -461.426% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -15992.888% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -368.131% |
| Statera Biopharma, Inc. | 28.82 Million USD | -1537.218% |
| ImmunityBio, Inc. | 362.87 Million USD | -30.074% |
| Korro Bio, Inc. | 84.53 Million USD | -458.358% |
| Kineta, Inc. | 21.15 Million USD | -2131.055% |
| BioVie Inc. | 31.95 Million USD | -1377.305% |
| Codexis, Inc. | 66.51 Million USD | -609.585% |
| Celularity Inc. | 215.05 Million USD | -119.477% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -108.278% |
| Celcuity Inc. | 66.23 Million USD | -612.667% |
| Virax Biolabs Group Limited | 6.54 Million USD | -7109.37% |
| Cibus, Inc. | 320.3 Million USD | -47.36% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -997.679% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -1294.64% |
| IN8bio, Inc. | 30.33 Million USD | -1455.862% |
| Kodiak Sciences Inc. | 277.32 Million USD | -70.201% |
| Annexon, Inc. | 143.72 Million USD | -228.411% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -269.934% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -1960.334% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -73650.313% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | 39.455% |
| Eyenovia, Inc. | 25.4 Million USD | -1757.804% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -236.387% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -8386.192% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -496.467% |
| Arcellx, Inc. | 200.19 Million USD | -135.766% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -928.327% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -118.104% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -4640.404% |
| Moolec Science SA | 52.75 Million USD | -794.78% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -672.027% |
| Geron Corporation | 70.44 Million USD | -570.067% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -914.186% |
| Royalty Pharma plc | 862.4 Million USD | 45.269% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -401.745% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -4960.128% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -1985.871% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -127.129% |
| Humacyte, Inc. | 23.49 Million USD | -1908.776% |
| Structure Therapeutics Inc. | 102.77 Million USD | -359.258% |
| 89bio, Inc. | 151.2 Million USD | -212.162% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -489.031% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -3146.231% |
| Genelux Corporation | 24.33 Million USD | -1839.601% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -1291.392% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -173.04% |
| Notable Labs, Ltd. | 14.77 Million USD | -3095.68% |
| Liquidia Corporation | 87.98 Million USD | -436.463% |
| Mustang Bio, Inc. | 48.5 Million USD | -873.18% |
| Immunovant, Inc. | 282.7 Million USD | -66.957% |
| Quantum-Si incorporated | 111.65 Million USD | -322.717% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -1993.692% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -2119.41% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -362.693% |
| Acasti Pharma Inc. | 11.3 Million USD | -4076.639% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -1959.246% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -2853.823% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -914.142% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -41501.474% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -2871.182% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -1518.829% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -1040.542% |
| PepGen Inc. | 84.76 Million USD | -456.829% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -1492.933% |
| United Therapeutics Corporation | 885.1 Million USD | 46.672% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -1961.414% |
| Solid Biosciences Inc. | 104.31 Million USD | -352.478% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -1342.305% |
| Immuneering Corporation | 58.41 Million USD | -708.044% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -9172.694% |
| Silo Pharma, Inc. | 3.92 Million USD | -11935.169% |
| Belite Bio, Inc | 31.66 Million USD | -1390.47% |
| XOMA Corporation | 46.46 Million USD | -915.866% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -598.745% |
| Bionomics Limited | 17.89 Billion USD | 97.362% |
| Apogee Therapeutics, Inc. | 93 Million USD | -407.513% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 1422.876% |
| uniQure N.V. | 285.08 Million USD | -65.565% |
| Cassava Sciences, Inc. | 105.95 Million USD | -345.466% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -6356.849% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -143.041% |
| Forte Biosciences, Inc. | 32.47 Million USD | -1353.342% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -5580.779% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -1505.722% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -8386.192% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -3221.619% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -5209.956% |
| Altimmune, Inc. | 30.55 Million USD | -1444.711% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -10.371% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 1422.876% |
| Compugen Ltd. | 43.97 Million USD | -973.439% |
| Peak Bio, Inc. | 1249.13 USD | -37786359.376% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -536.808% |
| Benitec Biopharma Inc. | 22.38 Million USD | -2008.846% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -94.089% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -1553.652% |
| Zura Bio Limited | 62.63 Million USD | -653.539% |
| PolyPid Ltd. | 21.04 Million USD | -2142.823% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -2799.988% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -1553.652% |
| Instil Bio, Inc. | 85.78 Million USD | -450.215% |
| argenx SE | 1.53 Billion USD | 69.221% |
| Immunome, Inc. | 122.82 Million USD | -284.304% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -873.742% |
| Verona Pharma plc | 67.15 Million USD | -602.894% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -1723.458% |
| Shattuck Labs, Inc. | 93.61 Million USD | -404.2% |
| CervoMed Inc. | 14.95 Million USD | -3055.565% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -567.584% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -5424.368% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -825.494% |
| Moolec Science SA | 52.75 Million USD | -794.78% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -2769.585% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -256.08% |
| AnaptysBio, Inc. | 181.56 Million USD | -159.959% |
| Design Therapeutics, Inc. | 78.19 Million USD | -503.66% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -442.275% |
| NeurAxis, Inc. | 8.82 Million USD | -5250.769% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -3650.513% |
| Lumos Pharma, Inc. | 38.66 Million USD | -1120.747% |
| Achilles Therapeutics plc | 75.25 Million USD | -527.204% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -1723.458% |
| 180 Life Sciences Corp. | 13.47 Million USD | -3402.148% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -1680.976% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -15992.888% |
| Nutriband Inc. | 5.73 Million USD | -8131.591% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -326.071% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -748.116% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -827.695% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -614.083% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -772.09% |
| Palisade Bio, Inc. | 13.32 Million USD | -3443.559% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -939.446% |
| Beam Therapeutics Inc. | 554.19 Million USD | 14.831% |
| Neurogene Inc. | 55.58 Million USD | -749.184% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -89.949% |
| AEON Biopharma, Inc. | 48.42 Million USD | -874.627% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -388.059% |
| Sesen Bio, Inc. | 78.38 Million USD | -502.189% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -465.076% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -3649.948% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -4.658% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -437.037% |
| Athira Pharma, Inc. | 125.46 Million USD | -276.199% |
| Vaccinex, Inc. | 23.45 Million USD | -1912.373% |
| HCW Biologics Inc. | 21.02 Million USD | -2144.687% |
| XOMA Corporation | 46.46 Million USD | -915.866% |
| Nektar Therapeutics | 190.9 Million USD | -147.247% |
| Arvinas, Inc. | 480 Million USD | 1.666% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -20656.738% |
| Merus N.V. | 200.49 Million USD | -135.42% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -356.68% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -1263.38% |
| Rezolute, Inc. | 70.38 Million USD | -570.581% |
| Clene Inc. | 41.07 Million USD | -1049.178% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -2781.844% |
| BeyondSpring Inc. | 24.86 Million USD | -1798.259% |
| Synlogic, Inc. | 58.53 Million USD | -706.4% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -2538.062% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -10407.614% |
| Peak Bio, Inc. | 1249.13 USD | -37786359.376% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -680.866% |
| Krystal Biotech, Inc. | 160.42 Million USD | -194.218% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -74.408% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -35.618% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -21785.035% |
| MannKind Corporation | 125.59 Million USD | -275.807% |
| Ikena Oncology, Inc. | 84.57 Million USD | -458.074% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -4792.733% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -426.782% |
| Gossamer Bio, Inc. | 183.75 Million USD | -156.859% |
| CohBar, Inc. | 12.38 Million USD | -3710.064% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -830.53% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -1611.268% |
| Legend Biotech Corporation | 583.14 Million USD | 19.059% |
| Mural Oncology plc | 192.07 Million USD | -145.744% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -602.938% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -2823.469% |
| Disc Medicine, Inc. | 91.12 Million USD | -417.972% |
| Champions Oncology, Inc. | 28.11 Million USD | -1579.125% |
| REGENXBIO Inc. | 321.15 Million USD | -46.969% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -8703.981% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -746.549% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -1111.484% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -312.744% |
| Vaxart, Inc. | 90.72 Million USD | -420.25% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -5439.924% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -1002.961% |
| Cellectis S.A. | 97.32 Million USD | -385.0% |
| Longeveron Inc. | 21.25 Million USD | -2121.186% |
| Repare Therapeutics Inc. | 167.35 Million USD | -182.033% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 65.315% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -523.97% |
| Revolution Medicines, Inc. | 498.76 Million USD | 5.366% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -6995.64% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -973.854% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -532.795% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -577.823% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -4167.649% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 90.115% |
| Denali Therapeutics Inc. | 527.23 Million USD | 10.475% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -5352.47% |
| Veru Inc. | 101.34 Million USD | -365.723% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -1916.499% |
| Cingulate Inc. | 22.75 Million USD | -1973.896% |
| Passage Bio, Inc. | 108.38 Million USD | -335.47% |
| Context Therapeutics Inc. | 25.07 Million USD | -1782.54% |
| Exicure, Inc. | 14.07 Million USD | -3253.24% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -129.056% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -990.049% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -5043.152% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -86.944% |
| Nuvalent, Inc. | 149.49 Million USD | -215.737% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -5751.094% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -355.381% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -2100.578% |
| OmniAb, Inc. | 83.89 Million USD | -462.61% |
| Anew Medical, Inc. | 1.3 Million USD | -36184.373% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -1340.612% |
| Lipocine Inc. | 15.08 Million USD | -3029.958% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -588.923% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -519.816% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1070.805% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -310.998% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -2008.658% |
| Sage Therapeutics, Inc. | 664.14 Million USD | 28.931% |
| Ocugen, Inc. | 71.56 Million USD | -559.525% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -402.847% |
| Q32 Bio Inc. | 92.68 Million USD | -409.281% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -2129.158% |
| Alumis Inc. Common Stock | 158.17 Million USD | -198.407% |
| Equillium, Inc. | 50.6 Million USD | -832.7% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -656.341% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -3294.341% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -2401.984% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -905.308% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -335.161% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -3708.702% |
| Dominari Holdings Inc. | 23.83 Million USD | -1880.289% |
| Edesa Biotech, Inc. | 9.22 Million USD | -5017.797% |
| vTv Therapeutics Inc. | 11.9 Million USD | -3864.072% |
| Bio-Techne Corporation | 563.03 Million USD | 16.169% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -15.459% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -75.625% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -256.828% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -3175.29% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -188.341% |
| Nkarta, Inc. | 131.65 Million USD | -258.528% |
| BioCardia, Inc. | 12.12 Million USD | -3794.085% |
| Iterum Therapeutics plc | 47.46 Million USD | -894.358% |